MediciNova Net Income from 2010 to 2024
| MNOV Stock | USD 1.90 0.21 12.43% |
Net Loss | First Reported 2004-03-31 | Previous Quarter -2.8 M | Current Value -2.6 M | Quarterly Volatility 3.9 M |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Net Income |
Latest MediciNova's Net Income Growth Pattern
Below is the plot of the Net Income of MediciNova over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in MediciNova financial statement analysis. It represents the amount of money remaining after all of MediciNova operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is MediciNova's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.57 M) | 10 Years Trend |
|
Net Income |
| Timeline |
MediciNova Net Income Regression Statistics
| Arithmetic Mean | (10,522,266) | |
| Coefficient Of Variation | (38.41) | |
| Mean Deviation | 2,944,814 | |
| Median | (10,865,979) | |
| Standard Deviation | 4,041,671 | |
| Sample Variance | 16.3T | |
| Range | 15.9M | |
| R-Value | (0.24) | |
| Mean Square Error | 16.6T | |
| R-Squared | 0.06 | |
| Significance | 0.38 | |
| Slope | (219,286) | |
| Total Sum of Squares | 228.7T |
MediciNova Net Income History
Other Fundumenentals of MediciNova
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
MediciNova Net Income component correlations
About MediciNova Financial Statements
MediciNova investors use historical fundamental indicators, such as MediciNova's Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -8.6 M | -9 M | |
| Net Loss | -8.6 M | -9 M | |
| Net Loss | -12.7 M | -13.3 M | |
| Net Loss | (0.17) | (0.18) | |
| Net Income Per E B T | 1.00 | 0.67 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.